A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy

Eric H Kossoff1, Jane R McGrogan, Renee M Bluml

  • 1John M. Freeman Pediatric Epilepsy Center, Departments of Neurology and Pediatrics, the Johns Hopkins Medical Institutions, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MS 21287-1000, U.S.A. ekossoff@jhmi.edu

Epilepsia
|February 28, 2006
PubMed

Insights

The modified Atkins diet effectively reduced seizures in children with intractable epilepsy. This well-tolerated therapy offers a promising treatment option for pediatric epilepsy management.

Area of Science:

  • Pediatric Neurology
  • Nutritional Neuroscience
  • Epileptology

Background:

  • Intractable childhood epilepsy often requires alternative treatment strategies.
  • The ketogenic diet is effective but can be difficult to adhere to.
  • The modified Atkins diet offers a less restrictive ketogenic approach.

Purpose of the Study:

  • To evaluate the efficacy of a modified Atkins diet for children with intractable epilepsy.
  • To assess the tolerability and safety of this dietary intervention.
  • To determine if the modified Atkins diet can induce ketosis without strict calorie or fluid restrictions.

Main Methods:

  • Prospective study of 20 children (aged 3-18) with drug-resistant epilepsy.
  • Dietary intervention involved carbohydrate restriction (10 g/day) and encouraged fat intake.
  • Monitoring included daily seizure logs, semiweekly urinary ketone measurements, and biochemical assessments.

Main Results:

  • All participants achieved moderate ketosis within 4 days.
  • 65% of children experienced >50% seizure reduction, with 35% achieving >90% improvement.
  • Four children became seizure-free; mean seizure frequency decreased significantly (p=0.005).
  • The diet was well-tolerated with no significant changes in weight or creatinine.

Conclusions:

  • The modified Atkins diet is a safe and effective treatment for intractable pediatric epilepsy.
  • It provides a viable, less restrictive alternative to traditional ketogenic diets.
  • This dietary therapy demonstrates significant potential for seizure control in children.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.